カテゴリ： 世界, 医療/バイオ, QYResearch

C1エステラーゼ阻害剤（皮下）の世界市場2023年：500U、1000U

■ 英語タイトル：Global C1 Esterase Inhibitor Subcutaneous Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8704）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8704
■ 発行日：2023年3月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：72
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥429,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥643,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥858,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[C1エステラーゼ阻害剤（皮下）の世界市場2023年：500U、1000U]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はC1エステラーゼ阻害剤（皮下）のグローバル市場について調査・分析し、世界のC1エステラーゼ阻害剤（皮下）市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（500U、1000U）、用途別セグメント分析（子供、大人）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Takeda、CSL Behringなどが含まれています。C1エステラーゼ阻害剤（皮下）のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、C1エステラーゼ阻害剤（皮下）市場規模を算出する際に考慮しました。

・C1エステラーゼ阻害剤（皮下）市場の概要
- 製品の定義
- C1エステラーゼ阻害剤（皮下）の種類別セグメント
- 世界のC1エステラーゼ阻害剤（皮下）市場規模：タイプ別分析（500U、1000U）
- C1エステラーゼ阻害剤（皮下）の用途別セグメント
- 世界のC1エステラーゼ阻害剤（皮下）市場規模：用途別分析（子供、大人）
- 世界のC1エステラーゼ阻害剤（皮下）市場規模予測（2018年-2029年）
- C1エステラーゼ阻害剤（皮下）の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- C1エステラーゼ阻害剤（皮下）市場の競争状況およびトレンド

・C1エステラーゼ阻害剤（皮下）の地域別市場規模
- 北米のC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- 米国のC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- ヨーロッパのC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- アジア太平洋のC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- 中国のC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- 日本のC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- 韓国のC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- インドのC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- オーストラリアのC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- 中南米のC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）
- 中東・アフリカのC1エステラーゼ阻害剤（皮下）市場規模（2018年-2029年）

・種類別セグメント：500U、1000U
- 世界のC1エステラーゼ阻害剤（皮下）のタイプ別販売量（2018年-2023年）
- 世界のC1エステラーゼ阻害剤（皮下）のタイプ別売上（2018年-2023年）
- 世界のC1エステラーゼ阻害剤（皮下）のタイプ別価格

・用途別セグメント：子供、大人
- 世界のC1エステラーゼ阻害剤（皮下）の用途別販売量（2018年-2023年）
- 世界のC1エステラーゼ阻害剤（皮下）の用途別売上（2018年-2023年）
- 世界のC1エステラーゼ阻害剤（皮下）の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Takeda、CSL Behring

・産業チェーンと販売チャネルの分析
- C1エステラーゼ阻害剤（皮下）産業チェーン分析
- C1エステラーゼ阻害剤（皮下）の主要原材料
- C1エステラーゼ阻害剤（皮下）の販売チャネル
- C1エステラーゼ阻害剤（皮下）のディストリビューター
- C1エステラーゼ阻害剤（皮下）の主要顧客

・C1エステラーゼ阻害剤（皮下）市場ダイナミクス
- C1エステラーゼ阻害剤（皮下）の業界動向
- C1エステラーゼ阻害剤（皮下）市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

 C1 esterase inhibitor is used to treat or prevent hereditary angioedema (HAE). 
Highlights
The global C1 Esterase Inhibitor Subcutaneous market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for C1 Esterase Inhibitor Subcutaneous is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for C1 Esterase Inhibitor Subcutaneous is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of C1 Esterase Inhibitor Subcutaneous include Takeda and CSL Behring etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for C1 Esterase Inhibitor Subcutaneous, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding C1 Esterase Inhibitor Subcutaneous.
The C1 Esterase Inhibitor Subcutaneous market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global C1 Esterase Inhibitor Subcutaneous market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the C1 Esterase Inhibitor Subcutaneous manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Takeda
CSL Behring
Segment by Type
500U
1000U
Segment by Application
Children
Adult
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of C1 Esterase Inhibitor Subcutaneous manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of C1 Esterase Inhibitor Subcutaneous in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 C1 Esterase Inhibitor Subcutaneous Market Overview
1.1 Product Overview and Scope of C1 Esterase Inhibitor Subcutaneous
1.2 C1 Esterase Inhibitor Subcutaneous Segment by Type
1.2.1 Global C1 Esterase Inhibitor Subcutaneous Market Value Comparison by Type (2023-2029)
1.2.2 500U
1.2.3 1000U
1.3 C1 Esterase Inhibitor Subcutaneous Segment by Application
1.3.1 Global C1 Esterase Inhibitor Subcutaneous Market Value by Application: (2023-2029)
1.3.2 Children
1.3.3 Adult
1.4 Global C1 Esterase Inhibitor Subcutaneous Market Size Estimates and Forecasts
1.4.1 Global C1 Esterase Inhibitor Subcutaneous Revenue 2018-2029
1.4.2 Global C1 Esterase Inhibitor Subcutaneous Sales 2018-2029
1.4.3 Global C1 Esterase Inhibitor Subcutaneous Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 C1 Esterase Inhibitor Subcutaneous Market Competition by Manufacturers
2.1 Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Manufacturers (2018-2023)
2.2 Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Manufacturers (2018-2023)
2.3 Global C1 Esterase Inhibitor Subcutaneous Average Price by Manufacturers (2018-2023)
2.4 Global C1 Esterase Inhibitor Subcutaneous Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of C1 Esterase Inhibitor Subcutaneous, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of C1 Esterase Inhibitor Subcutaneous, Product Type & Application
2.7 C1 Esterase Inhibitor Subcutaneous Market Competitive Situation and Trends
2.7.1 C1 Esterase Inhibitor Subcutaneous Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest C1 Esterase Inhibitor Subcutaneous Players Market Share by Revenue
2.7.3 Global C1 Esterase Inhibitor Subcutaneous Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 C1 Esterase Inhibitor Subcutaneous Retrospective Market Scenario by Region
3.1 Global C1 Esterase Inhibitor Subcutaneous Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global C1 Esterase Inhibitor Subcutaneous Global C1 Esterase Inhibitor Subcutaneous Sales by Region: 2018-2029
3.2.1 Global C1 Esterase Inhibitor Subcutaneous Sales by Region: 2018-2023
3.2.2 Global C1 Esterase Inhibitor Subcutaneous Sales by Region: 2024-2029
3.3 Global C1 Esterase Inhibitor Subcutaneous Global C1 Esterase Inhibitor Subcutaneous Revenue by Region: 2018-2029
3.3.1 Global C1 Esterase Inhibitor Subcutaneous Revenue by Region: 2018-2023
3.3.2 Global C1 Esterase Inhibitor Subcutaneous Revenue by Region: 2024-2029
3.4 North America C1 Esterase Inhibitor Subcutaneous Market Facts & Figures by Country
3.4.1 North America C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America C1 Esterase Inhibitor Subcutaneous Sales by Country (2018-2029)
3.4.3 North America C1 Esterase Inhibitor Subcutaneous Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe C1 Esterase Inhibitor Subcutaneous Market Facts & Figures by Country
3.5.1 Europe C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe C1 Esterase Inhibitor Subcutaneous Sales by Country (2018-2029)
3.5.3 Europe C1 Esterase Inhibitor Subcutaneous Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific C1 Esterase Inhibitor Subcutaneous Market Facts & Figures by Country
3.6.1 Asia Pacific C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific C1 Esterase Inhibitor Subcutaneous Sales by Country (2018-2029)
3.6.3 Asia Pacific C1 Esterase Inhibitor Subcutaneous Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America C1 Esterase Inhibitor Subcutaneous Market Facts & Figures by Country
3.7.1 Latin America C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America C1 Esterase Inhibitor Subcutaneous Sales by Country (2018-2029)
3.7.3 Latin America C1 Esterase Inhibitor Subcutaneous Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Facts & Figures by Country
3.8.1 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales by Country (2018-2029)
3.8.3 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global C1 Esterase Inhibitor Subcutaneous Sales by Type (2018-2029)
4.1.1 Global C1 Esterase Inhibitor Subcutaneous Sales by Type (2018-2023)
4.1.2 Global C1 Esterase Inhibitor Subcutaneous Sales by Type (2024-2029)
4.1.3 Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Type (2018-2029)
4.2 Global C1 Esterase Inhibitor Subcutaneous Revenue by Type (2018-2029)
4.2.1 Global C1 Esterase Inhibitor Subcutaneous Revenue by Type (2018-2023)
4.2.2 Global C1 Esterase Inhibitor Subcutaneous Revenue by Type (2024-2029)
4.2.3 Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Type (2018-2029)
4.3 Global C1 Esterase Inhibitor Subcutaneous Price by Type (2018-2029)
5 Segment by Application
5.1 Global C1 Esterase Inhibitor Subcutaneous Sales by Application (2018-2029)
5.1.1 Global C1 Esterase Inhibitor Subcutaneous Sales by Application (2018-2023)
5.1.2 Global C1 Esterase Inhibitor Subcutaneous Sales by Application (2024-2029)
5.1.3 Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Application (2018-2029)
5.2 Global C1 Esterase Inhibitor Subcutaneous Revenue by Application (2018-2029)
5.2.1 Global C1 Esterase Inhibitor Subcutaneous Revenue by Application (2018-2023)
5.2.2 Global C1 Esterase Inhibitor Subcutaneous Revenue by Application (2024-2029)
5.2.3 Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Application (2018-2029)
5.3 Global C1 Esterase Inhibitor Subcutaneous Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda C1 Esterase Inhibitor Subcutaneous Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Takeda C1 Esterase Inhibitor Subcutaneous Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL Behring
6.2.1 CSL Behring Corporation Information
6.2.2 CSL Behring Description and Business Overview
6.2.3 CSL Behring C1 Esterase Inhibitor Subcutaneous Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CSL Behring C1 Esterase Inhibitor Subcutaneous Product Portfolio
6.2.5 CSL Behring Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 C1 Esterase Inhibitor Subcutaneous Industry Chain Analysis
7.2 C1 Esterase Inhibitor Subcutaneous Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 C1 Esterase Inhibitor Subcutaneous Production Mode & Process
7.4 C1 Esterase Inhibitor Subcutaneous Sales and Marketing
7.4.1 C1 Esterase Inhibitor Subcutaneous Sales Channels
7.4.2 C1 Esterase Inhibitor Subcutaneous Distributors
7.5 C1 Esterase Inhibitor Subcutaneous Customers
8 C1 Esterase Inhibitor Subcutaneous Market Dynamics
8.1 C1 Esterase Inhibitor Subcutaneous Industry Trends
8.2 C1 Esterase Inhibitor Subcutaneous Market Drivers
8.3 C1 Esterase Inhibitor Subcutaneous Market Challenges
8.4 C1 Esterase Inhibitor Subcutaneous Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global C1 Esterase Inhibitor Subcutaneous Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global C1 Esterase Inhibitor Subcutaneous Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global C1 Esterase Inhibitor Subcutaneous Market Competitive Situation by Manufacturers in 2022
Table 4. Global C1 Esterase Inhibitor Subcutaneous Sales (Units) of Key Manufacturers (2018-2023)
Table 5. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Manufacturers (2018-2023)
Table 6. Global C1 Esterase Inhibitor Subcutaneous Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global C1 Esterase Inhibitor Subcutaneous Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market C1 Esterase Inhibitor Subcutaneous Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of C1 Esterase Inhibitor Subcutaneous, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of C1 Esterase Inhibitor Subcutaneous, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of C1 Esterase Inhibitor Subcutaneous, Product Type & Application
Table 12. Global Key Manufacturers of C1 Esterase Inhibitor Subcutaneous, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global C1 Esterase Inhibitor Subcutaneous by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in C1 Esterase Inhibitor Subcutaneous as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global C1 Esterase Inhibitor Subcutaneous Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global C1 Esterase Inhibitor Subcutaneous Sales by Region (2018-2023) & (Units)
Table 18. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Region (2018-2023)
Table 19. Global C1 Esterase Inhibitor Subcutaneous Sales by Region (2024-2029) & (Units)
Table 20. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Region (2024-2029)
Table 21. Global C1 Esterase Inhibitor Subcutaneous Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Region (2018-2023)
Table 23. Global C1 Esterase Inhibitor Subcutaneous Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Region (2024-2029)
Table 25. North America C1 Esterase Inhibitor Subcutaneous Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America C1 Esterase Inhibitor Subcutaneous Sales by Country (2018-2023) & (Units)
Table 27. North America C1 Esterase Inhibitor Subcutaneous Sales by Country (2024-2029) & (Units)
Table 28. North America C1 Esterase Inhibitor Subcutaneous Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America C1 Esterase Inhibitor Subcutaneous Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe C1 Esterase Inhibitor Subcutaneous Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe C1 Esterase Inhibitor Subcutaneous Sales by Country (2018-2023) & (Units)
Table 32. Europe C1 Esterase Inhibitor Subcutaneous Sales by Country (2024-2029) & (Units)
Table 33. Europe C1 Esterase Inhibitor Subcutaneous Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe C1 Esterase Inhibitor Subcutaneous Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific C1 Esterase Inhibitor Subcutaneous Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific C1 Esterase Inhibitor Subcutaneous Sales by Region (2018-2023) & (Units)
Table 37. Asia Pacific C1 Esterase Inhibitor Subcutaneous Sales by Region (2024-2029) & (Units)
Table 38. Asia Pacific C1 Esterase Inhibitor Subcutaneous Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific C1 Esterase Inhibitor Subcutaneous Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America C1 Esterase Inhibitor Subcutaneous Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America C1 Esterase Inhibitor Subcutaneous Sales by Country (2018-2023) & (Units)
Table 42. Latin America C1 Esterase Inhibitor Subcutaneous Sales by Country (2024-2029) & (Units)
Table 43. Latin America C1 Esterase Inhibitor Subcutaneous Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America C1 Esterase Inhibitor Subcutaneous Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa C1 Esterase Inhibitor Subcutaneous Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa C1 Esterase Inhibitor Subcutaneous Sales by Country (2018-2023) & (Units)
Table 47. Middle East & Africa C1 Esterase Inhibitor Subcutaneous Sales by Country (2024-2029) & (Units)
Table 48. Middle East & Africa C1 Esterase Inhibitor Subcutaneous Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa C1 Esterase Inhibitor Subcutaneous Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global C1 Esterase Inhibitor Subcutaneous Sales (Units) by Type (2018-2023)
Table 51. Global C1 Esterase Inhibitor Subcutaneous Sales (Units) by Type (2024-2029)
Table 52. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Type (2018-2023)
Table 53. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Type (2024-2029)
Table 54. Global C1 Esterase Inhibitor Subcutaneous Revenue (US$ Million) by Type (2018-2023)
Table 55. Global C1 Esterase Inhibitor Subcutaneous Revenue (US$ Million) by Type (2024-2029)
Table 56. Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Type (2018-2023)
Table 57. Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Type (2024-2029)
Table 58. Global C1 Esterase Inhibitor Subcutaneous Price (US$/Unit) by Type (2018-2023)
Table 59. Global C1 Esterase Inhibitor Subcutaneous Price (US$/Unit) by Type (2024-2029)
Table 60. Global C1 Esterase Inhibitor Subcutaneous Sales (Units) by Application (2018-2023)
Table 61. Global C1 Esterase Inhibitor Subcutaneous Sales (Units) by Application (2024-2029)
Table 62. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Application (2018-2023)
Table 63. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Application (2024-2029)
Table 64. Global C1 Esterase Inhibitor Subcutaneous Revenue (US$ Million) by Application (2018-2023)
Table 65. Global C1 Esterase Inhibitor Subcutaneous Revenue (US$ Million) by Application (2024-2029)
Table 66. Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Application (2018-2023)
Table 67. Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Application (2024-2029)
Table 68. Global C1 Esterase Inhibitor Subcutaneous Price (US$/Unit) by Application (2018-2023)
Table 69. Global C1 Esterase Inhibitor Subcutaneous Price (US$/Unit) by Application (2024-2029)
Table 70. Takeda Corporation Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda C1 Esterase Inhibitor Subcutaneous Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Takeda C1 Esterase Inhibitor Subcutaneous Product
Table 74. Takeda Recent Developments/Updates
Table 75. CSL Behring Corporation Information
Table 76. CSL Behring Description and Business Overview
Table 77. CSL Behring C1 Esterase Inhibitor Subcutaneous Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. CSL Behring C1 Esterase Inhibitor Subcutaneous Product
Table 79. CSL Behring Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. C1 Esterase Inhibitor Subcutaneous Distributors List
Table 83. C1 Esterase Inhibitor Subcutaneous Customers List
Table 84. C1 Esterase Inhibitor Subcutaneous Market Trends
Table 85. C1 Esterase Inhibitor Subcutaneous Market Drivers
Table 86. C1 Esterase Inhibitor Subcutaneous Market Challenges
Table 87. C1 Esterase Inhibitor Subcutaneous Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of C1 Esterase Inhibitor Subcutaneous
Figure 2. Global C1 Esterase Inhibitor Subcutaneous Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global C1 Esterase Inhibitor Subcutaneous Market Share by Type in 2022 & 2029
Figure 4. 500U Product Picture
Figure 5. 1000U Product Picture
Figure 6. Global C1 Esterase Inhibitor Subcutaneous Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global C1 Esterase Inhibitor Subcutaneous Market Share by Application in 2022 & 2029
Figure 8. Children
Figure 9. Adult
Figure 10. Global C1 Esterase Inhibitor Subcutaneous Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global C1 Esterase Inhibitor Subcutaneous Market Size (2018-2029) & (US$ Million)
Figure 12. Global C1 Esterase Inhibitor Subcutaneous Sales (2018-2029) & (Units)
Figure 13. Global C1 Esterase Inhibitor Subcutaneous Average Price (US$/Unit) & (2018-2029)
Figure 14. C1 Esterase Inhibitor Subcutaneous Report Years Considered
Figure 15. C1 Esterase Inhibitor Subcutaneous Sales Share by Manufacturers in 2022
Figure 16. Global C1 Esterase Inhibitor Subcutaneous Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest C1 Esterase Inhibitor Subcutaneous Players: Market Share by Revenue in 2022
Figure 18. C1 Esterase Inhibitor Subcutaneous Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global C1 Esterase Inhibitor Subcutaneous Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America C1 Esterase Inhibitor Subcutaneous Sales Market Share by Country (2018-2029)
Figure 21. North America C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Country (2018-2029)
Figure 22. United States C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe C1 Esterase Inhibitor Subcutaneous Sales Market Share by Country (2018-2029)
Figure 25. Europe C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Country (2018-2029)
Figure 26. Germany C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific C1 Esterase Inhibitor Subcutaneous Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Region (2018-2029)
Figure 33. China C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America C1 Esterase Inhibitor Subcutaneous Sales Market Share by Country (2018-2029)
Figure 43. Latin America C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Country (2018-2029)
Figure 44. Mexico C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Colombia C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa C1 Esterase Inhibitor Subcutaneous Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Country (2018-2029)
Figure 50. Turkey C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of C1 Esterase Inhibitor Subcutaneous by Type (2018-2029)
Figure 54. Global Revenue Market Share of C1 Esterase Inhibitor Subcutaneous by Type (2018-2029)
Figure 55. Global C1 Esterase Inhibitor Subcutaneous Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of C1 Esterase Inhibitor Subcutaneous by Application (2018-2029)
Figure 57. Global Revenue Market Share of C1 Esterase Inhibitor Subcutaneous by Application (2018-2029)
Figure 58. Global C1 Esterase Inhibitor Subcutaneous Price (US$/Unit) by Application (2018-2029)
Figure 59. C1 Esterase Inhibitor Subcutaneous Value Chain
Figure 60. C1 Esterase Inhibitor Subcutaneous Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • プレハブデータセンターモジュールのグローバル市場展望 2023年-2029年：500U以下、501-1000U、1001-2000U、2000U以上
  • 電磁式ナビゲーション気管支鏡（ENB）の世界市場2023年：治療、診断
  • 原発性硬化性胆管炎（PSC）の世界市場2023年：医療、肝移植、その他
  • 機器搬送システム（ETS）の世界市場2023年：点滴ポンプ用機器搬送システム（ETS）、内視鏡用機器搬送システム（ETS）、その他
  • フルサービス臨床研究機関（CRO）の世界市場2023年：臨床CRO、前臨床CRO
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8704 )"C1エステラーゼ阻害剤（皮下）の世界市場2023年：500U、1000U" (英文：Global C1 Esterase Inhibitor Subcutaneous Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。